Comparing two pain medicines after belly surgery in children with cancer
Compares nalbuphine and tramadol for pain relief after abdominal surgery in children with cancer.
Key facts
- Who runs it
- National Cancer Institute, Egypt
- Where
- Cairo, EgyptSee the site
- Trial code
- Registry title
- Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient
- Status
- Recruiting
- People taking part
- 128 people, planned
- Started
- 15 Jan 2025
- Planned end
- 15 Oct 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Nalbuphine
- Tramadol
- Record updated
- 11 August 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children aged 3-12 years who are having planned abdominal surgery under general anesthesia. It compares two pain medicines after surgery.
- Age
- 3 to 12 years
- Sex
- Boys and girls can both join.
- Disease stage
- Children with cancer who are scheduled for planned (elective) abdominal surgery under general anesthesia, with ASA class I-III.
- Earlier treatment
- Children who have long-term pain treated with opioids cannot join.
Main reasons for not taking part
- The child's guardian refuses
- Allergy to Tramal (tramadol) or nalbuphine
- Previous long-term pain treated with opioids
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Participants will be children aged 3-12 years
- American society of anesthesia (ASA) classification I-III
- scheduled for elective Abdominal surgery under general anesthesia
Who cannot take part
- Patient with previous chronic pain on opioids
- Allergy from Tramal or nalbuphine
- child guardian refusal
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 3 and 12 years old?
Where in Egypt
- National Cancer InstituteCairo, EgyptContact: Norma Osama AbdAllah Zayed, MDTaking people
About the trial
What the trial wants to find out
In current study the investigators aim to compare between nalbuphine versus tramadol for post-operative pain control in abdominal surgeries in pediatric.
The 2 groups in the trial
- nalbuphine (group A)Existing treatment, for comparison
group A (nalbuphine) will receive a single dose of nalbuphine (0.2 mg/kg) immediately after surgery to be repeated every 8 hours for the duration of the study (72 hours)
Treatment: Nalbuphine
- Tramadol (group B)Existing treatment, for comparison
group B( Tramadol) will receive a single dose of tramadol (2 mg/kg) immediately after surgery to be repeated every 8 hours for the duration of the study (72 hours).
Treatment: Tramadol
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Comparative Study Between Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient
- Plain-language title
- Comparing two pain medicines after belly surgery in children with cancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07110051, who can take part
- Record updated
- 11 August 2025